These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33034793)

  • 41. Patient Perspectives of Sickle Cell Management in the Emergency Department.
    Crego N; Masese R; Bonnabeau E; Douglas C; Rains G; Shah N; Tanabe P
    Crit Care Nurs Q; 2021 Apr-Jun 01; 44(2):160-174. PubMed ID: 33595963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait.
    Treadwell MJ; McClough L; Vichinsky E
    J Natl Med Assoc; 2006 May; 98(5):704-10. PubMed ID: 16749645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transition for Adolescents and Young Adults With Sickle Cell Disease in a US Midwest Urban Center: A Multilevel Perspective on Barriers, Facilitators, and Future Directions.
    Calhoun C; Luo L; Baumann AA; Bauer A; Shen E; McKay V; Hooley C; James A; King AA
    J Pediatr Hematol Oncol; 2022 Jul; 44(5):e872-e880. PubMed ID: 35731941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reflections of Healthcare Experiences of African Americans With Sickle Cell Disease or Cancer: A Qualitative Study.
    Dyal BW; Abudawood K; Schoppee TM; Jean S; Smith VM; Greenlee A; Staton LM; Duckworth L; Mandernach MW; Black V; Heldermon CD; Yao Y; Wilkie DJ; Ezenwa MO
    Cancer Nurs; 2021; 44(1):E53-E61. PubMed ID: 31743153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of race and disease on sickle cell patient wait times in the emergency department.
    Haywood C; Tanabe P; Naik R; Beach MC; Lanzkron S
    Am J Emerg Med; 2013 Apr; 31(4):651-6. PubMed ID: 23380119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.
    Karafin MS; Field JJ; Gottschall JL; Denomme GA
    Transfusion; 2015 Jun; 55(6 Pt 2):1399-406. PubMed ID: 25757390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in Sensory Pain, Expectation, and Satisfaction Reported by Outpatients with Cancer or Sickle Cell Disease.
    Ezenwa MO; Molokie RE; Wang ZJ; Yao Y; Suarez ML; Dyal B; Abudawood K; Wilkie DJ
    Pain Manag Nurs; 2018 Aug; 19(4):322-332. PubMed ID: 29501359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Sickle Cell Sabbath: a community program increases first-time blood donors in the African American faith community.
    Price CL; Johnson MT; Lindsay T; Dalton D; Watkins AR; DeBaun MR
    Transfusion; 2009 Mar; 49(3):519-23. PubMed ID: 19040492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensitivities to Thermal and Mechanical Stimuli: Adults With Sickle Cell Disease Compared to Healthy, Pain-Free African American Controls.
    Molokie RE; Wang ZJ; Yao Y; Powell-Roach KL; Schlaeger JM; Suarez ML; Shuey DA; Angulo V; Carrasco J; Ezenwa MO; Fillingim RB; Wilkie DJ
    J Pain; 2020; 21(9-10):957-967. PubMed ID: 31733363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of health literacy on emergency department utilization and hospitalizations in adolescents with sickle cell disease.
    Caldwell EP
    Public Health Nurs; 2019 Nov; 36(6):765-771. PubMed ID: 31402511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study.
    Hodges JR; Phillips SM; Norell S; Nwosu C; Khan H; Luo L; Badawy SM; King A; Tanabe P; Treadwell M; Rojas Smith L; Calhoun C; Hankins JS; Porter J
    Blood Adv; 2020 Sep; 4(18):4463-4473. PubMed ID: 32941646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study.
    Badawy SM; Abebe KZ; Reichman CA; Checo G; Hamm ME; Stinson J; Lalloo C; Carroll P; Saraf SL; Gordeuk VR; Desai P; Shah N; Liles D; Trimnell C; Jonassaint CR
    JMIR Res Protoc; 2021 May; 10(5):e29014. PubMed ID: 33988517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self-perceived loss of control and untreated dental decay in African American adults with and without sickle cell disease.
    Laurence B; Woods D; George D; Onyekwere O; Katz R; Lanzkron S; Diener-West M; Powe N
    J Health Care Poor Underserved; 2006 Aug; 17(3):641-51. PubMed ID: 16960327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana.
    Zempsky WT; Yanaros M; Sayeem M; Boruchov D; Piccone CM; Manwani D; Strunk C; Tartaglione I; Colombatti R; Akatue S; Oteng B; Owda A; Bamfo R; Wilson S; Rivers A; Farooq F; Urbonya R; Boatemaa GD; Rao S; Inusa B; Antwi-Boasiako C; Segbefia C; Sey F; Andemariam B; Asare EV; Campbell AD
    Pain Med; 2022 Aug; 23(8):1379-1386. PubMed ID: 35166851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How sickle cell disease patients experience, understand and explain their pain: An Interpretative Phenomenological Analysis study.
    Coleman B; Ellis-Caird H; McGowan J; Benjamin MJ
    Br J Health Psychol; 2016 Feb; 21(1):190-203. PubMed ID: 26333530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between elevated depressive symptoms and clinical disease severity in African-American adults with sickle cell disease.
    Laurence B; George D; Woods D
    J Natl Med Assoc; 2006 Mar; 98(3):365-9. PubMed ID: 16573300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals.
    Singh A; Brandow AM; Panepinto JA
    Blood Adv; 2021 Apr; 5(7):1915-1921. PubMed ID: 33792626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic diversity of CD14, CD28, CTLA-4 and ICOS gene promoter polymorphism in African and American sickle cell disease.
    Seamans BN; Pellechio SL; Capria AL; Agyingi SE; Morenikeji OB; Ojurongbe O; Thomas BN
    Hum Immunol; 2019 Nov; 80(11):930-936. PubMed ID: 31474499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infertility and treatment-seeking practices among females and males with sickle cell disease in the Sickle Cell Disease Implementation Consortium registry.
    Stevenson E; Tanabe P; Knisely M; Masese R; Bulgin D; Preiss L; Hankins JS; King AA; Gordeuk V; Shah N
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30356. PubMed ID: 37057750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.